These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14675605)

  • 21. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Paraneoplastic neurological autoimmune diseases].
    Voltz R
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
    [No Abstract]   [Full Text] [Related]  

  • 25. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
    Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human.
    Plonquet A; Garcia-Pons F; Fernandez E; Philippe C; Marquet J; Rouard H; Delfau-Larue MH; Kosmatopoulos K; Lemonnier F; Farcet JP; Gherardi RK; Langlade-Demoyen P
    J Neuroimmunol; 2003 Sep; 142(1-2):93-100. PubMed ID: 14512168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
    Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
    Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
    King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
    J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity.
    Hormigo A; Lieberman F
    J Neuroimmunol; 1994 Dec; 55(2):205-12. PubMed ID: 7829670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review.
    Tanaka K; Kawamura M; Sakimura K; Kato N
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.
    Drlicek M; Bianchi G; Bogliun G; Casati B; Grisold W; Kolig C; Liszka-Setinek U; Marzorati L; Wondrusch E; Cavaletti G
    J Neurol; 1997 Feb; 244(2):85-9. PubMed ID: 9120501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.
    de Jongste AH; de Graaf MT; Martinuzzi E; van den Broek PD; Kraan J; Lamers CH; Mallone R; Gratama JW; Sillevis Smitt PA
    Neuro Oncol; 2012 Jul; 14(7):841-8. PubMed ID: 22591661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
    Douglas CA; Ellershaw J
    Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.
    Shams'ili S; de Beukelaar J; Gratama JW; Hooijkaas H; van den Bent M; van 't Veer M; Sillevis Smitt P
    J Neurol; 2006 Jan; 253(1):16-20. PubMed ID: 16444604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
    Blatt J
    Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.